Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Cardiovascular Diseases (Phase 1)
Coronary Artery Bypass (Phase 2)
Coronary Artery Disease (Phase 2)
Coronary Vessels (Phase 1)
Endothelins (Phase 1)
Heart Disease Risk Factors (Phase 1)
Heart Failure (Phase 1)
Hypertension (Phase 1)
Hypertension, Pulmonary (Phase 2)
Metabolic Syndrome (Phase 1)
Multiple System Atrophy (Phase 1)
Myocardial Reperfusion Injury (Phase 2)
Proteinuria (Phase 1)
Pulmonary Disease, Chronic Obstructive (Phase 1)
Pure Autonomic Failure (Phase 1)
Renal Insufficiency, Chronic (Phase 1)
ST Elevation Myocardial Infarction (Phase 2)
Vascular Resistance (Phase 1)
Vasoconstriction (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue